# A Feasibility Study of Prophylactic White Blood Cell Transfusions

> **NCT01932710** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 45 (actual)

## Conditions studied

- Leukemia

## Interventions

- **PROCEDURE:** White Blood Cell Transfusion

## Key facts

- **NCT ID:** NCT01932710
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-20
- **Primary completion:** 2016-11-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932710, "A Feasibility Study of Prophylactic White Blood Cell Transfusions". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT01932710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*